Actual - Finance

My pick for the day is Waste Management (NYSE: WMI). Yeah sure, it is near

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

its 52 week high of $38.70. And yeah, the analyst estimates for 2007 are

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

for less profit than in '04,'05, and '06. But let's face it--WMI is a well

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

known brand in what I believe is an ever necessary business--waste & disp

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

osal services. They also have a great track record of delivering growth in

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

terms of profits. The stock currently pays a dividend of 2.52% (this by t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

he way is above their industry counterparts). So you not only have the pot

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ntial for capital appreciation but you also can derive a small income on t

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

his play to either buy more WMI or diversify your holdings.

Now best of a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ll, WMI just reported terrific results last week (up 19% compared to the s

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ame Quarter 1 year ago). That 19% shows us that these guys are turning thi

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ngs around and maybe, just maybe we'll find ourselves with a surprise for

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

2007 earnings.

How I'd play it: Buy a little now, and buy some more to ge

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t the Dollar Cost Averaging going in your favor on pull backs to the $31-$

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

3 range.

Disclaimer: InvestBlogger is an individual investor and he does

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

make mistakes. He encourages you to do your own research on any idea that

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

you may get from his blog because it may be incorrect. He also encourages

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

you to take ideas you get from this blog and discuss them with your financ

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ial adviser before making any investment as your financial position may be

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

very different from InvestBlogger and thus calls for a different strategy

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual.org.ua/article/101662/actual-I-Like--Waste-Management-WMI.html">I Like - Waste Management (WMI)</a>

BB link (for phorums):
[url=http://www.actual.org.ua/article/101662/actual-I-Like--Waste-Management-WMI.html]I Like - Waste Management (WMI)[/url]

Due to the World Wide Web's incredible growth rate, almost every sizable company (an even some small ones) are taking advantage of the opportunity to advertise internationally. Companies have come to realize that the Internet can be a very lucrative way to advertise, but one must be in constant participation in order to compete with each other. The Internet has become increasingly saturated with company web sites advertising and even doing business online.

It is truly fulfilling to have extravagant holidays, Christmas shopping, a car and a house. But all of these luxuries are not for free; they are pretty expensive to say the least. You have to either rob a bank or borrow some from it!

Tags

Links

Actual - I Like - Waste Management (WMI)

Related Articles: